In healthy individuals without cancer, the peptides promote normal healing processes
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Results are most noticeable when combined with a balanced diet, regular exercise, and consistency in your wellness routine over time
Safe, comfortable, and practical
The effects of dietary and physical activity interventions on tinnitus symptoms: An RCT
Ingredients Active Agents: BPC-157 (Pentadecapeptide) 10mg, TB-500 (Thymosin Beta-4 Analog) 10mg, GHK-Cu (Copper Tripeptide-1) 50mg Format: Sterile Lyophilized Powder (requires reconstitution) Ratio: Synergistic Research Blend (Total Concentration: 70mg per vial) Purity: 99% (HPLC Verified for all components)